Published ahead of print on December 18, 2003, doi:10.1164/rccm.200302-224OC
Am. J. Respir. Crit. Care Med., Volume 169, Number 6, March 2004, 687-695
A more recent version of this article appeared on March 15, 2004
Submitted on March 3, 2003
Accepted on December 11, 2003
Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice
J. David Holtzclaw1, Daniel Jack1, Samuel M Aguayo2, James R Eckman3, Jesse Roman4, and Lewis L Hsu1*
1 Pediatrics, Division of Hematology/Oncology and Bone Marrow Transplantation, Emory University School of Medicine, Atlanta, GA, USA,
2 Medicine, Atlanta Veterans Affairs Medical Center, Morehouse School of Medicine, Atlanta, GA, USA,
3 Hematology/Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA,
4 Pulmonary, Allergy and Critical Care Medicine, Emory University School of Medicine, Atlanta, GA, USA
* To whom correspondence should be addressed. E-mail: lewis_hsu{at}oz.ped.emory.edu.
Some suggest that sickle Cell Disease (SCD) is associated with a "proinflammatory state" that predisposes patients to acute chest syndrome in the setting of triggering factors. Conflicting data emerged when inflammation markers in SCD were compared to healthy individuals. Therefore, we examined transgenic sickle and control mice at baseline and with endotoxin (LPS) intraperitoneal injection to determine whether a proinflammatory state truly exists. At baseline, sickle mice had elevated levels of circulating leukocytes and sVCAM-1. No other differences were observed at baseline or in response to saline. However, LPS challenge was associated with significant increases in mortality (P<0.05), airway tone (P<0.03), serum and BAL levels of cytokines TNF (P<0.03), IL-1 (P<0.02), and sVCAM-1 (P<0.01) in Sickle mice compared to controls. Furthermore, 4 hours after LPS, microarray analysis identified 413 genes differentially expressed in the Sickle mice (n=5) compared to only 7 in the controls (n=5). No difference in lung parenchyma was observed by light microscopy. This enhanced response to LPS suggests that sickle RBC confer a subclinical "proinflammatory state". This enhanced response to inflammatory insult, particularly by adhesion molecules such as sVCAM-1, could play a role in the increased susceptibility to pulmonary dysfunction that has been observed clinically in SCD.
Key words: Inflammation, Cytokines, adhesion molecules, plethysmography, cDNA microarray
This article has been cited by other articles:

|
 |

|
 |
 
K. L. Wallace, M. A. Marshall, S. I. Ramos, J. A. Lannigan, J. J. Field, R. M. Strieter, and J. Linden
NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-{gamma} and CXCR3 chemokines
Blood,
July 16, 2009;
114(3):
667 - 676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Gladwin and E. Vichinsky
Pulmonary Complications of Sickle Cell Disease
N. Engl. J. Med.,
November 20, 2008;
359(21):
2254 - 2265.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Nandedkar, T. R. Feroah, W. Hutchins, D. Weihrauch, K. S. Konduri, J. Wang, R. C. Strunk, M. R. DeBaun, C. A. Hillery, and K. A. Pritchard
Histopathology of experimentally induced asthma in a murine model of sickle cell disease
Blood,
September 15, 2008;
112(6):
2529 - 2538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Hsu, H. C. Champion, S. A. Campbell-Lee, T. J. Bivalacqua, E. A. Manci, B. A. Diwan, D. M. Schimel, A. E. Cochard, X. Wang, A. N. Schechter, et al.
Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability
Blood,
April 1, 2007;
109(7):
3088 - 3098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Poster presentations
Thorax,
December 1, 2006;
61(suppl_2):
ii57 - ii133.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Bradley, Y. E. Miller, F. J. Martinez, D. C. Angus, W. MacNee, and E. Abraham
Interstitial Lung Disease, Lung Cancer, Lung Transplantation, Pulmonary Vascular Disorders, and Sleep-disordered Breathing in AJRCCM in 2004
Am. J. Respir. Crit. Care Med.,
April 1, 2005;
171(7):
675 - 685.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Greenough
Sickle Cell Disease--Pulmonary Complications and a Proinflammatory State?
Am. J. Respir. Crit. Care Med.,
March 15, 2004;
169(6):
663 - 665.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society
|
|
|